Amarin Corp Plcuk (AMRN) Receivables - Other (2010)
Amarin Corp Plc\Uk (AMRN) posted quarterly Receivables - Other of $351000.0 for Q4 2010.
Amarin Corp Plcuk (AMRN) Receivables - Other (2010) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Receivables - Other for 1 consecutive years, with $351000.0 the latest figure, recorded in Q4 2010.
- In Q4 2010, Receivables - Other changed N/A year-over-year to $351000.0; the TTM figure through Dec 2010 stood at $351000.0 (changed N/A YoY), while the FY2010 annual figure was $351000.0, changed N/A from the prior year.
- Receivables - Other held at $351000.0 in Q4 2010 per AMRN's latest filing.
- Across five years, Receivables - Other topped out at $351000.0 in Q4 2010 and bottomed at $351000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.88 Bn | 5.56 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 351,000.00 |
| Dec 31, 2010 | 351,000.00 |